Neutralizing antibodies for the prevention and treatment of COVID-19
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) initiates the infection
process by binding to the viral cellular receptor angiotensin-converting enzyme 2 through …
process by binding to the viral cellular receptor angiotensin-converting enzyme 2 through …
Monoclonal antibodies for COVID-19 therapy and SARS-CoV-2 detection
Abstract The coronavirus disease 2019 (COVID-19) pandemic is an exceptional public
health crisis that demands the timely creation of new therapeutics and viral detection. Owing …
health crisis that demands the timely creation of new therapeutics and viral detection. Owing …
Structural and functional ramifications of antigenic drift in recent SARS-CoV-2 variants
Neutralizing antibodies (nAbs) elicited against the receptor binding site (RBS) of the spike
protein of wild-type severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are …
protein of wild-type severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are …
Immunogenicity of Pfizer-BioNTech COVID-19 vaccine in patients with inborn errors of immunity
D Hagin, T Freund, M Navon, T Halperin, D Adir… - Journal of Allergy and …, 2021 - Elsevier
Background In mid-December 2020, Israel started a nationwide mass vaccination campaign
against coronavirus disease 2019 (COVID-19). In the first few weeks, medical personnel …
against coronavirus disease 2019 (COVID-19). In the first few weeks, medical personnel …
Lower serologic response to COVID-19 mRNA vaccine in patients with inflammatory bowel diseases treated with anti-TNFα
H Edelman-Klapper, E Zittan, ABG Shitrit… - Gastroenterology, 2022 - Elsevier
Background & Aim Patients with inflammatory bowel diseases (IBD), specifically those
treated with anti–tumor necrosis factor (TNF) α biologics, are at high risk for vaccine …
treated with anti–tumor necrosis factor (TNF) α biologics, are at high risk for vaccine …
A pandemic-enabled comparison of discovery platforms demonstrates a naïve antibody library can match the best immune-sourced antibodies
As a result of the SARS-CoV-2 pandemic numerous scientific groups have generated
antibodies against a single target: the CoV-2 spike antigen. This has provided an …
antibodies against a single target: the CoV-2 spike antigen. This has provided an …
Therapeutic role of neutralizing antibody for the treatment against SARS-CoV-2 and its emerging variants: A clinical and pre-clinical perspective
Since early 2020, the entire world has been facing a disastrous outbreak of the SARS-CoV-2
virus, with massive reporting of death and infections per day. Medical practitioners adopted …
virus, with massive reporting of death and infections per day. Medical practitioners adopted …
Monkeypox infection elicits strong antibody and B cell response against A35R and H3L antigens
Monkeypox virus (MPXV) resides in two forms; mature and enveloped, and depending on it,
distinct proteins are displayed on the viral surface. Here, we expressed two MPXV antigens …
distinct proteins are displayed on the viral surface. Here, we expressed two MPXV antigens …
A comprehensive review on immunogen and immune-response proteins of SARS-CoV-2 and their applications in prevention, diagnosis, and treatment of COVID-19
Exposure to severe acute respiratory syndrome-corona virus-2 (SARS-CoV-2) prompts
humoral immune responses in the human body. As the auxiliary diagnosis of a current …
humoral immune responses in the human body. As the auxiliary diagnosis of a current …
SARS-CoV-2 serology status detected by commercialized platforms distinguishes previous infection and vaccination adaptive immune responses
RT Suhandynata, NJ Bevins, JT Tran… - The journal of …, 2021 - academic.oup.com
Background The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has
infected over 110 million individuals and led to 2.5 million deaths worldwide. As more …
infected over 110 million individuals and led to 2.5 million deaths worldwide. As more …